Buserelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist used primarily to treat hormone-responsive conditions, including prostate cancer, endometriosis, and uterine fibroids, as well as… Read more
Buserelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist used primarily to treat hormone-responsive conditions, including prostate cancer, endometriosis, and uterine fibroids, as well as in assisted reproduction. Laboratories utilizing this peptide require high-quality reference standards to ensure the accuracy of their analytical testing and quality control procedures. Our selection includes the active pharmaceutical ingredient (API) alongside a range of related compounds, such as identified process-related and degradation impurities, to support comprehensive impurity profiling and method validation. For advanced quantitative analysis, particularly in complex biological matrices, we provide stable isotope-labelled compounds that function as internal standards. These materials are essential for verifying the selectivity and sensitivity of high-performance liquid chromatography and mass spectrometry methods during pharmaceutical development and rigorous regulatory testing.